# Drug-drug Interaction Study of SPH3127

> **NCT05359055** · PHASE1,PHASE2 · COMPLETED · sponsor: **Shanghai Pharmaceuticals Holding Co., Ltd** · enrollment: 40 (actual)

## Conditions studied

- Drug Drug Interaction

## Interventions

- **DRUG:** SPH3127 tablet
- **DRUG:** Itraconazole
- **DRUG:** SPH3127 tablet
- **DRUG:** Rifampin

## Key facts

- **NCT ID:** NCT05359055
- **Lead sponsor:** Shanghai Pharmaceuticals Holding Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-13
- **Primary completion:** 2022-01-21
- **Final completion:** 2022-01-21
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2022-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05359055

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05359055, "Drug-drug Interaction Study of SPH3127". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05359055. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*